Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katharine B. Feibus
Observed name:
Katharine Feibus
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0000-0001-5964-9048
Observed ORCID:
0000-0001-5964-9048
OpenAlex ID:
A5003269970
Scientific and regulatory activities initiated by the U.S. Food and drug administration to foster approvals of generic dry powder inhalers: Bioequivalence perspective
2022
·
Bryan Newman
, Andrew Babiskin
, et al.
·
Advanced Drug Delivery Reviews
·
19
Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective
2022
·
Nashwa El-Gendy
, Craig M. Bertha
, et al.
·
Advanced Drug Delivery Reviews
·
17
Generic substitution of epinephrine autoinjectors: Patient and caregiver perceptions and attitudes
2023
·
Sarah E. Ray
, Vanessa Boudewyns
, et al.
·
Journal of Allergy and Clinical Immunology Global
·
2
Comparative Use Human Factors Study of a Manual vs. A Partially Automated Pen Injector for GLP ‐1 Receptor Agonist Delivery
2026
·
Karthika Natarajan
, Andrew Clerman
, et al.
·
Clinical Pharmacology & Therapeutics
PDF
Development of Drug-Device Combination Products and Generic Substitution in the United States: An Overview
2025
·
YoonJung Lee
, Ila Srivastava
, et al.
·
INNOVATIONS in pharmacy
PDF
Show more works
View as search
Works count:
5
Citation count:
38
H-index:
2
I10-index:
2
Year
Topic
Type